Morphea secondary to interferon beta1b injection : a case and review of the literature
Interferon beta (IFNβ) is a drug used successfully in the treatment of multiple sclerosis (MS). Although IFNβ is a safe and well-tolerated drug, dermatological side effects are common. The most common dermatological adverse effect is a local reaction at the injection site. It may also cause inflammatory and immune-mediated dermatological side effects. However, morphea induced by IFNβ1b injection is very rare.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2019 |
---|---|
Erschienen: |
2019 |
Enthalten in: |
Zur Gesamtaufnahme - volume:25 |
---|---|
Enthalten in: |
Dermatology online journal - 25(2019), 4 vom: 15. Apr. |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Ozlu, Emin [VerfasserIn] |
---|
Themen: |
145155-23-3 |
---|
Anmerkungen: |
Date Completed 06.12.2019 Date Revised 17.12.2019 published: Electronic Citation Status MEDLINE |
---|
Förderinstitution / Projekttitel: |
|
---|
PPN (Katalog-ID): |
NLM29666524X |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM29666524X | ||
003 | DE-627 | ||
005 | 20231225090328.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2019 xx |||||o 00| ||eng c | ||
028 | 5 | 2 | |a pubmed24n0988.xml |
035 | |a (DE-627)NLM29666524X | ||
035 | |a (NLM)31046913 | ||
035 | |a (PII)13030/qt41v3p52s | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Ozlu, Emin |e verfasserin |4 aut | |
245 | 1 | 0 | |a Morphea secondary to interferon beta1b injection |b a case and review of the literature |
264 | 1 | |c 2019 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 06.12.2019 | ||
500 | |a Date Revised 17.12.2019 | ||
500 | |a published: Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Interferon beta (IFNβ) is a drug used successfully in the treatment of multiple sclerosis (MS). Although IFNβ is a safe and well-tolerated drug, dermatological side effects are common. The most common dermatological adverse effect is a local reaction at the injection site. It may also cause inflammatory and immune-mediated dermatological side effects. However, morphea induced by IFNβ1b injection is very rare | ||
650 | 4 | |a Case Reports | |
650 | 4 | |a Journal Article | |
650 | 4 | |a Review | |
650 | 7 | |a Adjuvants, Immunologic |2 NLM | |
650 | 7 | |a Interferon beta-1b |2 NLM | |
650 | 7 | |a 145155-23-3 |2 NLM | |
700 | 1 | |a Karadag, Ayse Serap |e verfasserin |4 aut | |
700 | 1 | |a Akdeniz, Necmettin |e verfasserin |4 aut | |
700 | 1 | |a Uzuncakmak, Tugba Kevser |e verfasserin |4 aut | |
700 | 1 | |a Zemheri, Ebru |e verfasserin |4 aut | |
700 | 1 | |a Ozkanli, Seyma |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Dermatology online journal |d 1997 |g 25(2019), 4 vom: 15. Apr. |w (DE-627)NLM090971183 |x 1087-2108 |7 nnns |
773 | 1 | 8 | |g volume:25 |g year:2019 |g number:4 |g day:15 |g month:04 |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 25 |j 2019 |e 4 |b 15 |c 04 |